Pfizer's once-a-month weight loss shot shows early promise, but years from approval

Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years ...

Pfizer’s new weight-loss shot: Can one injection a month change obesity treatment as we know it?

With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising ...
NewsNation on MSN

What to know about berobenatide, Pfizer’s experimental obesity drug

Berobenatide injections would only need to be taken 12 times a year rather than 52 with weekly injections.

The next goal for weight loss drugs? Fewer injections

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.